DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "South Africa Generics Medicine Market Outlook 2022" report to their offering.
It is anticipated that the generic medicine market is forecasted to grow at a CAGR of around 12% during 2017-2022.
Access to therapeutic drugs form an integral part of any successful healthcare system. The high cost of drugs, however, remains a barrier to accessibility and improved health to the majority of the South African population. The promotion of generic drug consumption was the answer to this issue, with its massive cost-saving mechanism in regard for the final consumers, insurance providers, and government. In 2001, the South African Government passed the law that allowed substitution of branded medicines with generic drugs, which in turn made South Africa a huge market space for the generic drug manufacturing pharmaceutical companies.
The report South Africa Generics Medicine Market Outlook 2022 provides a current and future perspective of the market. It provides an overview of the Healthcare market of South Africa, focusing on its two major segments of Public Healthcare and Private Healthcare. It further gives a detailed analysis of the South African Pharmaceutical market, with an in-depth study of the Generic Drug market scenario prevalent in the country.
The research also talks about the competitive landscape of the key players, such as Teva, Aspen, Adcock Ingram, Cipla, and Pharma Dynamics. On the whole, the report provides information that will prove to be vital for investors interested in the domestic market.
Key Topics Covered:
1. Analyst View
2. Research Methodology
3. Healthcare Market Overview
4. Market Attractions
5. Pharmaceutical Market Overview
6. Generics Medicine Market Outlook to 2022
7. Emerging Market Trends
8. Market Challenges
9. Regulatory Environment
10. Competitive Landscape
- Adcock Ingram
- Aspen Generics
- Cipla South Africa
- Pharma Dynamics
- Teva Pharmaceuticals
For more information about this report visit http://www.researchandmarkets.com/research/vfzrqr/south_africa